| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA658405 | F | Drug concentration causing 50% lethality against human cancer line of CNS | Homo sapiens | 3 | ALA1135975 | cell-based format | Scientific Literature | |
| 2. | ALA658142 | F | Lethal concentration was determined against CNS cancer cell line | Homo sapiens | 5 | ALA1133703 | cell-based format | Scientific Literature | |
| 3. | ALA658143 | F | The compound was tested for its growth inhibitory activity against CNS cancer cell line | Homo sapiens | 4 | ALA1133062 | cell-based format | Scientific Literature | |
| 4. | ALA654308 | F | In vitro cytotoxicity against CNS cancer cells | Homo sapiens | 11 | ALA1133583 | cell-based format | Scientific Literature | |
| 5. | ALA4200378 | F | Antiproliferative activity against human CNS cancer cells at 10 to 100 nM after 48 hrs by SRB assay | Homo sapiens | 1 | ALA4196149 | cell-based format | Scientific Literature | |
| 6. | ALA4320819 | F | Cytotoxicity against human CNS cancer cells after 48 hrs by SRB assay | Homo sapiens | 15 | ALA4316599 | cell-based format | Scientific Literature | |
| 7. | ALA4738935 | F | Growth inhibition of human CNS carcinoma cell incubated for 48 hrs by sulforhodamine B assay | Homo sapiens | 3 | ALA4732237 | cell-based format | Scientific Literature | |
| 8. | ALA5096389 | F | Cytotoxicity against human CNS carcinoma cells assessed as reduction in cell viability by MTT assay relative to control | Homo sapiens | 2 | ALA5096145 | cell-based format | Scientific Literature | |
| 9. | ALA5249572 | F | Cytotoxicity against human CNS carcinoma cell assessed as growth percent at 10 uM incubated for 48 hrs | Homo sapiens | 1 | ALA5247603 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!